open access

Vol 82, No 5 (2011)
ARTICLES
Get Citation

Expression of podoplanin in ovarian clear cell carcinoma

Józef Kotarski, Barbara Marzec-Kotarska, Justyna Szumiło, Robert Klepacz, Marek Cybulski, Małgorzata Sobstyl, Wiesława Bednarek
Ginekol Pol 2011;82(5).

open access

Vol 82, No 5 (2011)
ARTICLES

Abstract

Abstract Introduction: Podoplanin is a transmembrane glycoprotein expressed in endothelial lymphatic cells. It was proven to be a predictive marker in a variety of cancers e.g. mesothelioma and head and neck squamous-cell carcinoma. Ovarian clear cell carcinoma (OCCC) is a rare and unique histopathologic subtype of epithelial ovarian cancer (EOC). The molecular basis of that phenomenon remains unknown. Objectives: The aim of our study was to assess podoplanin expression on the protein level in OCCC. Material and Methods: Immunohistochemistry was performed on paraffin-embedded tissues from 19 patients with diagnosed OCCC. Results: Podoplanin expression was present (moderate or strong) in 52% of OCCC cases (10/19). Nine of eleven (81,2%) postmenopausal and one of eight (12,5%) premenopausal women were podoplanin positive. No differences in podoplanin expression were found in relation to clinical features of the tumor. Conclusion: The incidence of podoplanin expression is higher in ovarian clear cell adenocarcinoma in postmenopausal patients.

Abstract

Abstract Introduction: Podoplanin is a transmembrane glycoprotein expressed in endothelial lymphatic cells. It was proven to be a predictive marker in a variety of cancers e.g. mesothelioma and head and neck squamous-cell carcinoma. Ovarian clear cell carcinoma (OCCC) is a rare and unique histopathologic subtype of epithelial ovarian cancer (EOC). The molecular basis of that phenomenon remains unknown. Objectives: The aim of our study was to assess podoplanin expression on the protein level in OCCC. Material and Methods: Immunohistochemistry was performed on paraffin-embedded tissues from 19 patients with diagnosed OCCC. Results: Podoplanin expression was present (moderate or strong) in 52% of OCCC cases (10/19). Nine of eleven (81,2%) postmenopausal and one of eight (12,5%) premenopausal women were podoplanin positive. No differences in podoplanin expression were found in relation to clinical features of the tumor. Conclusion: The incidence of podoplanin expression is higher in ovarian clear cell adenocarcinoma in postmenopausal patients.
Get Citation

Keywords

clear cell carcinoma, ovarian epithelial cancer

About this article
Title

Expression of podoplanin in ovarian clear cell carcinoma

Journal

Ginekologia Polska

Issue

Vol 82, No 5 (2011)

Page views

616

Article views/downloads

693

Bibliographic record

Ginekol Pol 2011;82(5).

Keywords

clear cell carcinoma
ovarian epithelial cancer

Authors

Józef Kotarski
Barbara Marzec-Kotarska
Justyna Szumiło
Robert Klepacz
Marek Cybulski
Małgorzata Sobstyl
Wiesława Bednarek

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl